Literature DB >> 16985619

Peripheral blood rt-PCR assays for detection and prognosis of prostate cancer.

Shahrokh F Shariat, Kevin M Slawin.   

Abstract

Entities:  

Year:  2003        PMID： 16985619      PMCID： PMC1472997     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  30 in total

1.  Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy.

Authors:  T Okegawa; K Nutahara; E Higashihara
Journal:  BJU Int       Date:  1999-07       Impact factor: 5.588

2.  Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.

Authors:  C L Gao; S Maheshwari; R C Dean; L Tatum; R Mooneyhan; R R Connelly; D G McLeod; S Srivastava; J W Moul
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

3.  Natural history of progression after PSA elevation following radical prostatectomy.

Authors:  C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

4.  Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy.

Authors:  A de la Taille; C A Olsson; R Buttyan; M C Benson; E Bagiella; Y Cao; M Burchardt; D K Chopin; A E Katz
Journal:  Int J Cancer       Date:  1999-08-20       Impact factor: 7.396

5.  Quantitative reverse transcription-PCR assay with an internal standard for the detection of prostate-specific antigen mRNA.

Authors:  A Ylikoski; M Sjöroos; A Lundwall; M Karp; T Lövgren; H Lilja; A Iitiä
Journal:  Clin Chem       Date:  1999-09       Impact factor: 8.327

6.  Molecular expression of PSMA mRNA and protein in primary renal tumors.

Authors:  F Dumas; J L Gala; P Berteau; F Brasseur; P Eschwège; V Paradis; B Lacour; M Philippe; S Loric
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

7.  Clinical and molecular followup after radical retropubic prostatectomy.

Authors:  M G Oefelein; J M Ignatoff; J Q Clemens; W Watkin; K L Kaul
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

8.  The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer.

Authors:  W J Ellis; R L Vessella; E Corey; E W Arfman; M M Oswin; S Melchior; P H Lange
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

9.  Prostate specific antigen reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer.

Authors:  J M Ignatoff; M G Oefelein; W Watkin; J S Chmiel; K L Kaul
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

10.  Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.

Authors:  Y Zhang; C D Zippe; F Van Lente; E A Klein; M K Gupta
Journal:  Clin Cancer Res       Date:  1997-07       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.